SmartBio Analytics recently had the pleasure of welcoming Jesús Moreno, Mayor of Tres Cantos, as part of an institutional visit to several innovative companies located within the Qube Technology Park at the Madrid Science and Technology ecosystem.
👉 Read the full external news coverage here:
https://360y5.es/el-alcalde-visita-diferentes-empresas-del-complejo-biotecnologico-qube-en-el-ptm/
This visit highlights the strong commitment of the local government to supporting high-value industries such as biotechnology, pharmaceuticals, and advanced scientific services, positioning Tres Cantos as one of the leading biotech hubs in Spain and Southern Europe.
Showcasing SmartBio Analytics’ Bioanalytical Capabilities
During the visit, the SmartBio team presented its state-of-the-art laboratory facilities and discussed how the company supports drug development through advanced bioanalytical services based on LC-MS/MS.
As a GLP-certified bioanalytical CRO (Good Laboratory Practice, certified by the Madrid regional health authorities), SmartBio Analytics specializes in:
- Bioanalytical method development and validation
- Quantification of small and large molecules (including peptides, lipids, oligonucleotides, and proteins)
- Support for preclinical (GLP) and clinical (GCP-compliant) studies
- Pharmacokinetic (PK) and bioequivalence studies
SmartBio plays a key role in accelerating the development of new therapies by providing high-quality, regulatory-compliant data to pharmaceutical and biotech companies.
Tres Cantos: A Growing Life Sciences Hub in Madrid
The visit also underscored the importance of Qube Technology Park as a dynamic innovation hub, hosting more than 30 life sciences companies and fostering collaboration across the biotech ecosystem.
Located in Madrid, Tres Cantos has become a strategic location for biotech companies, CROs, and pharmaceutical R&D, benefiting from:
- Proximity to leading hospitals and clinical research centers
- A strong talent pool in life sciences and engineering
- A growing network of innovative startups and established companies
Strengthening Public-Private Collaboration in Biotech
At SmartBio Analytics, we highly value initiatives like this visit, which strengthen the connection between public institutions and innovative companies.
Support from local authorities is essential to continue building a competitive and internationally recognized biotech ecosystem—one that enables companies like SmartBio to grow, innovate, and contribute to the development of new medicines.
We would like to thank the Mayor and his team for their visit and interest in our work.